KMTS
Common StockKESTRA MEDICAL TECHNOLOGIES, LTD.
Reported Shares
2.7M
Position Mix
No options reported
Reported Value
$77.2M
Portfolio Weight
43.94%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$175.7M
Data Refreshed
Nov 16, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
KMTS
Common StockKESTRA MEDICAL TECHNOLOGIES, LTD.
Reported Shares
2.7M
Position Mix
No options reported
Reported Value
$77.2M
Portfolio Weight
43.94%
MLYS
Common StockMineralys Therapeutics, Inc.
Reported Shares
1.6M
Position Mix
No options reported
Reported Value
$40.0M
Portfolio Weight
22.77%
AVLN
Common StockAvalyn Pharma Inc.
Reported Shares
929.8K
Position Mix
No options reported
Reported Value
$26.5M
Portfolio Weight
15.08%
AGMB
Depositary ReceiptAgomab Therapeutics NV
Reported Shares
1.5M
Position Mix
No options reported
Reported Value
$17.1M
Portfolio Weight
9.72%
IVA
Depositary ReceiptInventiva S.A.
Reported Shares
3.6M
Position Mix
No options reported
Reported Value
$13.4M
Portfolio Weight
7.63%
EVMN
Common StockEvommune, Inc.
Reported Shares
97.4K
Position Mix
No options reported
Reported Value
$804.2K
Portfolio Weight
0.46%
NYXH
Common StockNyxoah SA
Reported Shares
522.1K
Position Mix
No options reported
Reported Value
$720.4K
Portfolio Weight
0.41%